It’s time to take the first step: to have a conversation with your doctor about the changes you’ve been experiencing, how your health is being affected, and whether these signs and symptoms could be ...

It’s time to take the first step: to have a conversation with your doctor about the changes you’ve been experiencing, how your health is being affected, and whether these signs and symptoms could be ...

Together, these cytokines affect a number of immune cell types and cellular pathways that have been found to be abnormal in lupus. In addition, IL-12 and IL-23 signalling occurs upstream in the ...

Looking ahead, the researchers plan to study how these immune pathways behave during lupus flare-ups and remissions, with the ...

Changes associated with the disease were found in multiple molecules in the blood of people with lupus. The changes resulted in insufficient activation of a pathway that the aryl hydrocarbon ...

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.